New device hopes to boost leg blood flow in veterans with PAD and nerve damage
NCT ID NCT07336381
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using the Replexa+ device twice daily for 3 months can improve blood flow in the lower legs and feet of veterans with peripheral artery disease (PAD) and peripheral neuropathy. Ten participants will have their blood flow measured before and after treatment. The goal is to see if this shortwave therapy eases symptoms and improves circulation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Richard L. Roudebush Veterans Affairs Medical Center
Indianapolis, Indiana, 46202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Beetroot juice may boost heart blood flow and walking in leg artery disease
- Can a Pre-Surgery skin coating stop wound infections?
- Can a 'Scoring' balloon unclog leg arteries better and reduce stents?
- Can a temporary stent keep leg arteries open?
- Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
- Can a Lab-Grown artery graft outlast current options?